Skip to main content

Company News

April 15, 2024

bioMérieux Named Business of the Year by Utah Governor’s Office of Economic Opportunity

bioMérieux, a world leader in the field of in vitro diagnostics, has received the 2024 Business of the Year Award, presented by the Utah Governor’s Office of Economic Opportunity at One Utah Summit April 11-12, in Salt Lake City.
Discover More

  • March 19, 2024

    bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens

    bioMérieux has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens.
    Read more

  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
    Read more

  • April 20, 2023

    bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

    bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.
    Read more

  • February 21, 2023

    bioMérieux launches a PCR kit for detection of the monkeypox virus

    bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.
    Read more

Follow us on Socials for more news!